ArticleSensors (Basel, Switzerland)2026
Cloud-to-Edge Deployment of Optimized nnU-Net for Ischemic Stroke Lesion Segmentation on Resource-Constrained Embedded Devices.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Ischemic stroke remains a leading cause of global mortality and long-term neurological disability, where the "Time is Brain" paradigm dictates that rapid and accurate lesion assessment is fundamental for effective clinical intervention. While the nnU-Net v2 framework has established a new state of the art in medical image segmentation, its high computational demands and reliance on data-center-grade GPUs hinder its translation into real-time, point-of-care clinical workflows. This study presents a technical feasibility analysis of a Cloud-to-Edge optimization pipeline designed to transfer a 3D nnU-Net v2 model from a high-performance cloud environment to a resource-constrained embedded device. Experimental results showed that edge deployment was associated with a reduction in overlap-based segmentation metrics compared with the cloud reference, with Dice decreasing from approximately 0.78 to 0.67. However, TensorRT FP32 and FP16 inference produced nearly identical mean segmentation metrics, suggesting that reduced-precision inference did not introduce additional measurable degradation under the evaluated conditions. The optimized FP16 configuration achieved a processing time of 10.2 s per 3D volume, representing a 33% reduction compared with embedded FP32 inference, while operating within a low-power envelope of approximately 10-13 W. These findings support the preliminary technical feasibility of executing advanced 3D volumetric segmentation models on low-power edge hardware. Nevertheless, the evaluation was limited to an internal 25-case test subset and did not include external validation, prospective clinical assessment, or reader studies. Therefore, the proposed system should be interpreted as a preliminary deployment framework rather than a clinically validated tool for autonomous stroke imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.